Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-374-750"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-374-750"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-374-8752
lpv:speaker	lp:Nuno Teixeira2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with South Africa (2009-09-16--2014-06-30)3 member; Delegation for relations with the Mercosur countries (2010-01-18--2014-06-30)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; TRAN (2012-01-19--2014-06-30)3 member; REGI (2012-01-19--2014-06-30)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3
lpv:translated text	"This proposal for a directive is a response to preventing cases like that of ‘Mediator’ in France, which jeopardised the lives of thousands and killed some 500 to 2 000 people. The amendments to the 2010 directive aim to make pharmacology legislation more effective with regard to collecting signs and acting on their detection, and to increasing cooperation between Member States. Following the ‘stress tests’ conducted by the EU, a range of measures have been presented, with a view to improving the system proposed by the 2010 directive, particularly the inclusion of an automatic urgent procedure, a new trigger for the urgent procedure, clarification of transparency obligations on companies, and a longer list of medicines subject to additional monitoring. These measures will increase the effectiveness and vigilance of the authorities competent in this regard. Simultaneously, they aim to increase cooperation between Member States."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph